NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Kidney Innovation Accelerator

Kidney Innovation Accelerator

Washington D.C.kidneyx.org

Overview

Kidney Innovation Accelerator is a public-private partnership between the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) that accelerates innovation in the prevention, diagnosis, and treatment of kidney diseases through prize competitions.

Year Founded

2018

Portfolio Companies

5

Investments

Kidney Innovation Accelerator investments
CompanyDateStageLead
Qidni LabsJan 2025GrantLead
Makana TherapeuticsJun 2023GrantCo-investor
Trestle BiotherapeuticsJun 2023GrantCo-investor
Makana TherapeuticsNov 2021GrantCo-investor
US Kidney Research CorporationNov 2021GrantLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersWashington D.C.
Year Founded2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.